Ascensia Diabetes Care announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the CONTOUR ® NEXT ONE Blood Glucose Monitoring System (BGMS), marking a key step in ...
BASEL, Switzerland--(BUSINESS WIRE)--Today, Ascensia Diabetes Care announced that it has received CE Mark (Conformité Européenne) for the new CONTOUR™ NEXT ONE and CONTOUR™ PLUS ONE blood glucose ...
July 16, 2007 -- A class 1 recall has been issued for a glucose monitoring system ( Ascensia Contour [product 7152A], Bayer Healthcare) because of its inappropriate display of measurements in ...
BASEL, Switzerland, May 2, 2022 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, maker of CONTOUR ® blood glucose monitoring (BGM) system portfolio and distributor of the ...
MISSISSAUGA, ON, Jan. 18, 2017 /CNW/ - Ascensia Diabetes Care today announced that they have received a license from Health Canada for the CONTOUR ® NEXT LINK 2.4 blood glucose meter to be used with ...
HONG KONG, Sept. 30, 2019 /PRNewswire/ -- At the 21st Diabetes and Cardiovascular Risk Factors – East Meets West Symposium, Ascensia Diabetes Care has presented data from two studies, one analyzing ...
In recent years, diabetes tech makers like Dexcom and Insulet have made their devices’ data available via smartphone, putting the ability to track and analyze real-time glucose levels and insulin ...
Robert Schumm, VP and Managing Director of Ascensia Diabetes Care US Inc., said: "We believe the MiniMed ® 670G system offers significant advantages to current insulin pump products available in the U ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback